![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, October 05, 2015 6:46:50 AM
Not in Europe, but wife is science educated and her business deals with same regulatory bodies. Her insight is historically it has been easier for new drug approvals in Europe (not really a revelation). IMO knowing Germany appears to have been producing more vaccine for HE then anyone was aware of it's plausible the Germans are pursuing approval for L. One would hope the agencies are working in consort as the bar is not too high for GBM. Hopefully we see soon. (revelation for Mav. Investment in NW could be viewed as bet against wife's business. And in hindsight probably a good thing for me the "Carlos Danger" alias was not available on ihub if my hidden online identity were exposed. Talk about Woodford being totally unhedged......)
I'm not an attorney, but deal with attorneys on a regular basis. I was recently involved in a patent infringement trial our lead counsel and co-counsel were woman. The ability of quality legal talent to grasp what would be for most foreign technical concepts can be eye opening. I sense NW is graced with such talent and we are too online glad to see some latitude from posters in respect to the latter. IMO not good to be overwrought with caution I do understand the reason for caution. I have 20 or so patents in technical area and think the melding of automation and this science holds great promise (see post 37108) to coax cells to do things and do it better outside of their normal environment. Hence my interest with Direct and the automated production. Incidentally we were victorious in the patent suit.
Part of my surreal week around this space two weeks ago involves helping chemo recipient with penguin cold caps to retain their hair look this up online. Second time in four years I've done this worked the first time. This time will be more intensive regimen adriamycin is one of the chemo's for those,of you who know chemo. I'll offer my insights to anyone here who would like to discuss (I'll sign up for PM)
As for SP assuming no squeeze $30 with full approval for L and double it with two partners for phase II direct trials. Not too brief
I'm here primarily for the pop up ads I'm just that impulsive......
Recent NWBO News
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM